Simultaneous analytical measurement of multiple protein biomarkers continues to hold promise in the identification of molecular signatures that may impact research applications, ranging from ...

The Centers for Disease Control and Prevention estimates that one in every four deaths in the United States is due to cancer, yet approximately one-third of all cancer cases could be prevented if ...

A quantitative reverse transcriptase polymerase chain reaction assay to identify metastatic carcinoma tissue of origin No significant financial relationships to disclose. This is an ASCO Meeting ...

Emerging opportunities in diagnostics include rapid and point-of-care testing, consumer markets, and biomarker development. Immunoassays are expanding due to genetic advances, with multiplex becoming ...

Stroke is among the most common neurologic disorders and a leading cause of death anddisability worldwide. Among the most long-lasting consequences of stroke and cerebrovasculardisease is cognitive ...

Hematuria may occur in up to 10% of the general population and results in costly evaluation to ensure it is of no consequence, i.e., no bladder cancer (BCa) is present since hematuria is typically the ...

Messenger molecules such as cytokines are involved in the communication within the immune system and play a vital role in a variety of conditions including cancer and autoimmune diseases. Advancing ...

The "Multiplex Assays Market by Type (Protein [Bead, Planar], Nucleic Acid, Cell), Technology (Flow Cytometry, PCR, Immunoassay), Application (R&D, Diagnosis ...

Reverse phase protein array is a high-throughput technology that performs protein assays on thousands of samples simultaneously, including tissue and cell lysates, serum, plasma or other body fluids.

The global immunoassay market is projected to expand at a compound annual growth rate (CAGR) of approximately 6–7% over the ...